Misplaced Pages

Trideca-7,9,11-trienoic acid: Difference between revisions

Article snapshot taken from Wikipedia with creative commons attribution-sharealike license. Give it a read and then ask your questions in the chat. We can research this topic together.
Browse history interactively← Previous editNext edit →Content deleted Content addedVisualWikitext
Revision as of 02:44, 3 January 2025 editExpulldordiamania (talk | contribs)87 editsNo edit summary← Previous edit Revision as of 02:47, 3 January 2025 edit undoExpulldordiamania (talk | contribs)87 editsNo edit summaryNext edit →
Line 27: Line 27:
}} }}


'''Trideca-7,9,11-trienoic acid''', or '''(7E,9E,11E)-trideca-7,9,11-trienoic acid''', is an ]. It is present in '']''. It has been shown to have an antianxiety effect in '']'', '']'', and '']''. It causes hypolocomotion in ''Mus musculus'' and ''Rattus norvegicus''. A 2mg/Kg dose of ] has a very similiar effect to 20mg/Kg of trideca-7,9,11-trienoic acid.<ref name="three">{{cite journal |last1=Shri |first1=Richa |last2=Bhutani |first2=K.K. |last3=Sharma |first3=Anupam |year=2010 |title=A new anxiolytic fatty acid from Aethusa cynapium |journal=Fitoterapia |volume=81 |issue=5 |pages=337–340 |doi=10.1016/j.fitote.2010.05.003}}</ref><ref>{{cite patent }}Compounds and compositions for treating CNS disorders, Kerry L. Spear, Douglas Burdi, WO2021138314A1, WIPO, 8.7.2021. (https://patents.google.com/patent/WO2021138314A1/en)</ref><ref>{{Cite web |title=(7E,9E,11E)-trideca-7,9,11-trienoic acid |publisher=National Library of Medicine |work=PubChem |url=https://pubchem.ncbi.nlm.nih.gov/compound/(7E-9E-11E)-trideca-7-9-11-trienoic-acid}} 3.1.2025.</ref> '''Trideca-7,9,11-trienoic acid''', or '''(7E,9E,11E)-trideca-7,9,11-trienoic acid''', is an ]. It is present in '']''. It has been shown to have an antianxiety effect in '']'', '']'', and '']''. It causes hypolocomotion in ''Mus musculus'' and ''Rattus norvegicus''. A 2mg/Kg dose of ] has a very similiar effect to 20mg/Kg of trideca-7,9,11-trienoic acid.<ref name="three">{{cite journal |last1=Shri |first1=Richa |last2=Bhutani |first2=K.K. |last3=Sharma |first3=Anupam |year=2010 |title=A new anxiolytic fatty acid from Aethusa cynapium |journal=Fitoterapia |volume=81 |issue=5 |pages=337–340 |doi=10.1016/j.fitote.2010.05.003}}</ref><ref>{{cite patent }}Compounds and compositions for treating CNS disorders, Kerry L. Spear, Douglas Burdi, WO2021138314A1, WIPO, 8.7.2021. (https://patents.google.com/patent/WO2021138314A1/en)</ref><ref>{{Cite web |title=(7E,9E,11E)-trideca-7,9,11-trienoic acid |publisher=National Library of Medicine |work=PubChem |url=https://pubchem.ncbi.nlm.nih.gov/compound/(7E-9E-11E)-trideca-7-9-11-trienoic-acid}} 3.1.2025.</ref><ref>{{Cite patent |title=Composition for ink vehicles and protective coatings |publication-number=EP0503897A1 |inventor=Gerald Sugarman, Michael W. O'Neill |assignee=Topez Co |date=1992-09-16 |url=https://patents.google.com/patent/EP0503897A1}}</ref>


==References== ==References==

Revision as of 02:47, 3 January 2025

Trideca-7,9,11-trienoic acid
Names
IUPAC name (7E,9E,11E)-trideca-7,9,11-trienoic acid
Identifiers
3D model (JSmol)
ChemSpider
PubChem CID
InChI
  • InChI=1S/C13H20O2/c1-2-3-4-5-6-7-8-9-10-11-12-13(14)15/h2-7H,8-12H2,1H3,(H,14,15)/b3-2+,5-4+,7-6+¨Key: CMKVWQNTXKWDNT-ICDJNDDTSA-N
SMILES
  • C/C=C/C=C/C=C/CCCCCC(=O)O
Properties
Chemical formula C13H20O2
Molar mass 208.301 g·mol
Except where otherwise noted, data are given for materials in their standard state (at 25 °C , 100 kPa). Infobox references
Chemical compound

Trideca-7,9,11-trienoic acid, or (7E,9E,11E)-trideca-7,9,11-trienoic acid, is an polyunsaturated fatty acid. It is present in Aethusa cynapium. It has been shown to have an antianxiety effect in Mus musculus, Rattus norvegicus, and Homo sapiens. It causes hypolocomotion in Mus musculus and Rattus norvegicus. A 2mg/Kg dose of diazepam has a very similiar effect to 20mg/Kg of trideca-7,9,11-trienoic acid.

References

  1. Shri, Richa; Bhutani, K.K.; Sharma, Anupam (2010). "A new anxiolytic fatty acid from Aethusa cynapium". Fitoterapia. 81 (5): 337–340. doi:10.1016/j.fitote.2010.05.003.
  2.  Compounds and compositions for treating CNS disorders, Kerry L. Spear, Douglas Burdi, WO2021138314A1, WIPO, 8.7.2021. (https://patents.google.com/patent/WO2021138314A1/en)
  3. "(7E,9E,11E)-trideca-7,9,11-trienoic acid". PubChem. National Library of Medicine. 3.1.2025.
  4. EP0503897A1, Gerald Sugarman, Michael W. O'Neill, "Composition for ink vehicles and protective coatings", assigned to Topez Co 
Category: